Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.2190
+0.0090 (4.29%)
May 13, 2025, 4:00 PM - Market closed
Ernexa Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | -46.09 | -44.54 | -21.67 | -24.58 | -122.55 | -7.29 | Upgrade
|
| Depreciation & Amortization | 1.17 | 1.64 | 1.12 | 0.5 | 0.46 | 0.1 | Upgrade
|
| Other Amortization | 4.81 | 5.26 | 0.3 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | - | 0 | 0.28 | 9.66 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 6.76 | 80.54 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 0.07 | 0.94 | - | - | Upgrade
|
| Stock-Based Compensation | 1.74 | 1.52 | 1.24 | 2.94 | 5.24 | 0.09 | Upgrade
|
| Other Operating Activities | 26.95 | 22.26 | 0.64 | -11.52 | 5.46 | - | Upgrade
|
| Change in Accounts Payable | -0.33 | 0.18 | -2.9 | 2.03 | -0.49 | -0.93 | Upgrade
|
| Change in Unearned Revenue | -0.53 | -0.58 | 0.58 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -1.86 | -1.58 | 0.2 | 1.68 | -1.81 | -0.07 | Upgrade
|
| Operating Cash Flow | -14.15 | -15.84 | -20.41 | -20.98 | -23.49 | -8.1 | Upgrade
|
| Capital Expenditures | -0.27 | -0.37 | -0.02 | -0.3 | -0.15 | -0.04 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0 | - | 0.25 | - | - | Upgrade
|
| Cash Acquisitions | - | - | - | - | -22.71 | - | Upgrade
|
| Divestitures | - | - | - | - | 0.12 | - | Upgrade
|
| Investing Cash Flow | -0.27 | -0.37 | -0.02 | -0.05 | -22.74 | -0.04 | Upgrade
|
| Short-Term Debt Issued | - | - | 1.5 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 5.29 | 16.5 | - | - | 0.31 | Upgrade
|
| Total Debt Issued | 6.14 | 5.29 | 18 | - | - | 0.31 | Upgrade
|
| Short-Term Debt Repaid | - | - | -1.5 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0 | -0.94 | - | Upgrade
|
| Total Debt Repaid | - | - | -1.5 | -0 | -0.94 | - | Upgrade
|
| Net Debt Issued (Repaid) | 6.14 | 5.29 | 16.5 | -0 | -0.94 | 0.31 | Upgrade
|
| Issuance of Common Stock | 1.14 | 1.14 | 0.32 | 19.71 | 62.54 | 4.36 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -0.01 | - | - | Upgrade
|
| Preferred Dividends Paid | - | - | -0.02 | -0.02 | -0.01 | - | Upgrade
|
| Dividends Paid | - | - | -0.02 | -0.02 | -0.01 | - | Upgrade
|
| Other Financing Activities | -0.15 | -0.17 | -0.25 | -0.11 | - | - | Upgrade
|
| Financing Cash Flow | 7.13 | 6.26 | 16.56 | 19.58 | 61.59 | 4.67 | Upgrade
|
| Net Cash Flow | -7.29 | -9.94 | -3.87 | -1.44 | 15.36 | -3.47 | Upgrade
|
| Free Cash Flow | -14.42 | -16.21 | -20.43 | -21.27 | -23.64 | -8.14 | Upgrade
|
| Free Cash Flow Margin | -2695.70% | -2784.36% | -30039.71% | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.56 | -1.19 | -3.84 | -6.97 | -10.92 | -9.26 | Upgrade
|
| Cash Interest Paid | 0.05 | 0.05 | 0.02 | 0.03 | 0.23 | - | Upgrade
|
| Cash Income Tax Paid | 0 | 0 | 0 | 0.02 | 0 | - | Upgrade
|
| Levered Free Cash Flow | -2.02 | -7.18 | -13.45 | -10.25 | -12.4 | -6.02 | Upgrade
|
| Unlevered Free Cash Flow | -2.62 | -8.22 | -13.37 | -10.23 | -12.36 | -5.99 | Upgrade
|
| Change in Net Working Capital | -3.84 | 0.23 | 2.79 | -3.65 | 0.75 | 1.61 | Upgrade
|
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.